NASDAQ:JAZZ - Nasdaq - IE00B4Q5ZN47 - Common Stock - Currency: USD
Taking everything into account, JAZZ scores 6 out of 10 in our fundamental rating. JAZZ was compared to 198 industry peers in the Pharmaceuticals industry. While JAZZ belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on JAZZ. With these ratings, JAZZ could be worth investigating further for value investing!.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 4.66% | ||
ROE | 13.68% | ||
ROIC | 5.29% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 18.06% | ||
PM (TTM) | 13.77% | ||
GM | 89.05% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 1.49 | ||
Debt/FCF | 4.54 | ||
Altman-Z | 1.54 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 4.46 | ||
Quick Ratio | 3.99 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 5.23 | ||
Fwd PE | 4.66 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 4.99 | ||
EV/EBITDA | 6.65 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
110.8
+1.82 (+1.67%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 5.23 | ||
Fwd PE | 4.66 | ||
P/S | 1.65 | ||
P/FCF | 4.99 | ||
P/OCF | 4.82 | ||
P/B | 1.64 | ||
P/tB | N/A | ||
EV/EBITDA | 6.65 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 4.66% | ||
ROE | 13.68% | ||
ROCE | 6.7% | ||
ROIC | 5.29% | ||
ROICexc | 7.27% | ||
ROICexgc | 38.48% | ||
OM | 18.06% | ||
PM (TTM) | 13.77% | ||
GM | 89.05% | ||
FCFM | 33.13% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 1.49 | ||
Debt/FCF | 4.54 | ||
Debt/EBITDA | 4.36 | ||
Cap/Depr | 7.28% | ||
Cap/Sales | 1.18% | ||
Interest Coverage | 2.33 | ||
Cash Conversion | 100.07% | ||
Profit Quality | 240.63% | ||
Current Ratio | 4.46 | ||
Quick Ratio | 3.99 | ||
Altman-Z | 1.54 |